Funding News: 22 April 2011

In This Issue:

• * Research funding

• * Student and institutional support programs

• * GrantsNet Express

  * Deadline Watch

• * GrantsNet sponsorship

New Research Funding Programs

Department of Health and Human Services. National Institutes of Health

Next Generation PrEP II (R01)

The National Institute of Allergy and Infectious Diseases (NIAID) encourages applications from institutions/organizations to participate in this funding opportunity announcement (FOA), Next Generation PrEP. The purpose of this FOA is to: (1) develop the basic and preclinical framework needed for development of second and subsequent generations of PrEP agents; (2) create a rational pipeline for the discovery of new molecular entities and the identification of existing antiretrovirals (including those that are approved for HIV treatment and those that are not approved but may have clinical data) that can be used for the next generation of PrEP agents; (3) develop preclinical algorithms with clear go/no-go criteria for identifying and prioritizing PrEP candidates for advancement to clinical evaluation; (4) generate PK/PD models to assess protective effects at mucosal sites of HIV transmission; and (5) conduct proof-of-concept safety and efficacy studies in animal models. NIAID intends to commit approximately $3.2 million for this FOA for fiscal year 2012 to fund three to five applications. Deadline: 2011-08-08; 2011-09-08

Department of Health and Human Services. National Institutes of Health

Optimizing Fidelity of Empirically-Supported Behavioral Treatments for Mental Disorders (R21/R33)

This funding opportunity announcement (FOA) seeks research applications designed to develop and test methods for improving the fidelity, and ultimately the effectiveness, of empirically supported behavioral treatments (ESBTs) implemented by front-line therapists in community-practice settings. Because achieving this aim presumes valid and reliable assessment of fidelity, this FOA uses the sequential R21/R33 funding mechanisms to encourage research designed to develop and test (a) methods for assessing theory-derived ESBT fidelity components during the R21 phase and (b) interventions that enhance and maintain the fidelity with which clinicians implement an ESBT in community-practice settings during the R33 phase. The National Institute of Mental Health intends to commit approximately $1.5 million in fiscal year 2012 to fund up to seven grants in response to this FOA. Deadline: 2011-05-20; 2011-06-20

Department of Health and Human Services. National Institutes of Health

Basic Research in Calcific Aortic Valve Disease (R01)

This funding opportunity announcement funds molecular and physiological research that could lead to early diagnosis or effective medical therapy for calcific aortic valve disease. Applications from investigators in related fields (for example, mineralization and bone physiology, extracellular matrix physiology, and molecular imaging) are strongly encouraged. Applicants must describe in the application how the proposed research could lead to early diagnosis or effective medical therapy for calcific aortic valve disease. The National Heart, Lung and Blood Institute expects to commit $4 million total costs per year to support the award of up to 10 awards. The maximum award budget is $250,000 direct costs per year. The maximum award period is 4 years. Deadline: 2011-09-12; 2011-10-11

Department of Health and Human Services. National Institutes of Health

Life After Linkage: The Future of Family Studies (R01)

This funding opportunity announcement issued by the National Heart, Lung and Blood Institute (NHLBI) and the National Human Genome Research Institute (NHGRI) solicits applications which integrate novel molecular data with existing genotype and phenotype data in families to identify and characterize genes influencing complex disorders. Applications for this program should have previously examined families with some genotyping and phenotypes available. Proposals may utilize focused ascertainment from families, for example, using risk profile, extreme phenotypes, or families contributing heavily to genomic signals. The program may support the addition of targeted or whole-genome sequencing, exon sequencing, copy-number variants, expression profiling, metabolomics, epigenomics, and/or novel biomarkers. This may require additional sample collection and/or reconsent. Applications should include a strong analytic component focused on bioinformatics and integration of multiple data types. NHLBI intends to commit $26.8 million over 5 years to fund five to seven grants. NHGRI intends to commit $5 million over 5 years to the program. Deadline: 2011-05-16; 2011-06-15

Department of Health and Human Services. National Institutes of Health

Pilot Studies to Develop and Test Novel, Low- Cost Methods for the Conduct of Clinical Trials (R01)

The funding announcement solicits R01 applications that develop and test new, low cost methods to conduct clinical trials. Responsive applicants will address four challenges to the conduct of clinical trials: (1) minimize specialized infrastructure, (2) minimize visits designed solely for the trial, (3) explore novel methods of obtaining consent that minimize burden, and (4) employ low-cost methods of monitoring study conduct. The proposed methodology must be tested in a pilot trial. New and innovative designs that have not been tested in previous studies but hold potential for increasing the efficiency and reducing the cost of conduct of clinical trials are especially encouraged. The National Heart, Lung, and Blood Institute intends to commit $8,550,000 for fiscal years 2012-2015, to fund up to three awards. Deadline: 2011-09-13; 2011-10-13

Department of Health and Human Services. National Institutes of Health

Pulmonary Vascular-Right Ventricular Axis Research Program (R01)

This funding opportunity announcement solicits research grant applications from organizations proposing to study right ventricular (RV) function, dysfunction, and disease. Utilizing a multidisciplinary and collaborative team approach, this program will foster research that will lead to improved diagnostics and therapeutics for RV disease, particularly in the setting of lung vascular disease. Human subjects research must be proposed, and applicants are strongly encouraged to use the multiple principal investigator approach to study the right ventricular-pulmonary vascular axis. The National Heart, Lung and Blood Institute intends to commit $4,050,000 for up to six awards in fiscal year 2012. Deadline: 2011-09-13; 2011-10-13

Department of Health and Human Services. National Institutes of Health

Development and Translation of Medical Technologies to Reduce Health Disparities (R43/R44)

This funding opportunity announcement encourages Small Business Innovation Research grant applications from small-business concerns that propose to develop and translate medical technologies aimed at reducing disparities in health care access and health outcomes. Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them. Responsive grant applications must involve a formal collaboration with a health care provider or other health care organization serving a health-disparity population during phase I and phase II. Budgets up to $200,000 total costs per year for phase I and up to $400,000 total costs per year for phase II may be requested. Durations up to 2 years for phase I and up to 3 years for phase II may be requested. Deadline: 2011-08-22; 2011-09-22

Department of Health and Human Services. National Institutes of Health

NIH Blueprint for Neuroscience Research Grand Challenge: Developing Novel Drugs for Disorders of the Nervous System (U01)

The National Institutes of Health announces a unique opportunity for investigators working with small-molecule compounds to gain access to a robust virtual pharma drug-development network to develop neurotherapeutic drugs. Successful applicants to this funding opportunity announcement will become collaborative participants in this network, receiving both funding and no-cost access to contracted drug-development services that are not typically available to the academic research community. Funding will be provided through a U01 cooperative agreement mechanism to conduct biological testing of compound analogs in disease assays and models in the investigator's laboratory. No-cost drug-development services will also be provided, including medicinal chemistry optimization, IND-directed pharmacology and toxicology, and phase I clinical testing. Researchers in possession of disease assays and small-molecule compounds that show promise for treating nervous system and psychiatric disorders, but that are not yet suitable for clinical testing, are strongly encouraged to apply. The participating institutes/centers intend to commit up to $2,325,000 in fiscal year 2012 to fund up to 13 awards. Deadline: 2011-05-10; 2011-06-10; 2011-11-15; 2011-12-15

GrantsNet Express

GrantsNet Express offers a new listing each week by e-mail of science funding opportunities from private foundations and organizations, as well as new U.S. government science grant announcements.

New Student and Institutional Support Programs

Department of Health and Human Services. National Institutes of Health

Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral M.D./Ph.D and Other Dual Doctoral Degree Fellows (Parent F30)

The purpose of the Ruth L. Kirschstein National Research Service Awards (Kirschstein-NRSA) is to provide support to individuals for combined M.D./Ph.D. and other dual doctoral degree training. The participating institutes award this Kirschstein-NRSA individual fellowship (F30) to qualified applicants with the potential to become productive, independent, highly trained physician-scientists and other clinician-scientists, including patient-oriented researchers in their scientific mission areas. This funding opportunity supports individual predoctoral F30 fellowships with the expectation that these training opportunities will increase the number of future investigators with both clinical knowledge and skills in basic, translational, or clinical research. Deadline: 2011-08-08; 2011-12-08

[ top ]

Deadline Watch

Department of Health and Human Services. National Institutes of Health

Program Project on Alcohol-Related Research (P01)

Deadline: 2011-04-25; 2011-05-25; 2012-04-25; 2012-05-25

Department of Health and Human Services. National Institutes of Health

Predoctoral and Postdoctoral Training Program in Reproductive, Obstetric, Perinatal and Pediatric Epidemiology and Pharmacoepidemiology (T32)

Deadline: 2011-04-25; 2011-05-25

Department of Health and Human Services. National Institutes of Health

Specialized Cooperative Centers Program in Reproduction and Infertility Research (U54)

Deadline: 2011-04-26; 2011-05-26

Department of Health and Human Services. National Institutes of Health

Grand Opportunity in Medications Development for Substance-Related Disorders (U01)

Deadline: 2011-04-26; 2011-05-26; 2011-07-26; 2011-08-26

Department of Health and Human Services. National Institutes of Health

Genomic Resource Grants for Community Resource Projects (U41)

Deadline: 2011-04-26; 2011-05-25; 2011-08-27; 2011-09-25

Department of Health and Human Services. National Institutes of Health

Partnerships for Biodefense (R01)

Deadline: 2011-04-27; 2011-05-27

American Academy of Child and Adolescent Psychiatry

AACAP Pilot Research Award for Attention Disorders, Supported by the Elaine Schlosser Lewis Fund

Deadline: 2011-04-29

American Academy of Child and Adolescent Psychiatry

AACAP Pilot Research Award for Junior Faculty and Child Psychiatry Fellows, Supported by Lilly USA, LLC

Deadline: 2011-04-29

American Academy of Child and Adolescent Psychiatry

AACAP Pilot Research Award for Learning Disabilities, Supported by the Elaine Schlosser Lewis Fund

Deadline: 2011-04-29

Applied Separations, Inc.

Supercritical Fluid Educational Grant (SCF-PRIME-11)

Deadline: 2011-04-30

Wellcome Trust/ DBT India Alliance

India Alliance Margdarshi Fellowships

Deadline: 2011-05-01

Department of Health and Human Services. National Institutes of Health

Model Systems for Fragile X Pre-Mutation and Primary Ovarian Insufficiency (FX-POI) (R21)

Deadline: 2011-05-01; 2011-06-01; 2012-05-01; 2012-06-01

Department of Health and Human Services. National Institutes of Health

Education Research in Sleep Health and Sleep-Circadian Biology (R25)

Deadline: 2011-05-03; 2011-06-02; 2012-01-02; 2012-02-02

Royal Society of New Zealand

Rutherford Discovery Fellowships

Deadline: 2011-05-04

Environmental Protection Agency

Developing High-Throughput Assays for Predictive Modeling of Reproductive and Developmental Toxicity Modulated Through the Endocrine System or Pertinent Pathways in Humans and Species Relevant to Ecological Risk Assessment

Deadline: 2011-05-05

Department of Health and Human Services. National Institutes of Health

Research Opportunities in Obstetric Fistula (R01)

Deadline: 2011-05-05; 2011-06-05; 2011-10-05; 2012-02-05

Department of Health and Human Services. National Institutes of Health

Studies in Neonatal Hypoglycemia (R01)

Deadline: 2011-05-07; 2011-06-05; 2011-09-06; 2011-10-05

Department of Health and Human Services. National Institutes of Health

Mechanisms of Adverse Drug Reactions in Children (R01)

Deadline: 2011-05-07; 2011-06-05; 2011-09-06; 2011-10-05

Department of Health and Human Services. National Institutes of Health

Developmental Pharmacology (R01)

Deadline: 2011-05-07; 2011-06-05; 2011-09-06; 2011-10-05

Queensland Health

Senior Clinical Research Fellowships (Round Three)

Deadline: 2011-05-09

Department of Health and Human Services. National Institutes of Health

Integrating Multi-Dimensional Data to Explore Mechanisms Underlying Mental Disorders (RO1)

Deadline: 2011-05-09; 2011-06-09

Department of Health and Human Services. National Institutes of Health

NIH Blueprint for Neuroscience Research Grand Challenge: Developing Novel Drugs for Disorders of the Nervous System (U01)

Deadline: 2011-05-10; 2011-06-10; 2011-11-15; 2011-12-15

National Science Foundation

Chemistry and Materials Research in Cultural Heritage Science

Deadline: 2011-05-11

Department of Health and Human Services. National Institutes of Health

Institutional Clinical and Translational Science Award (U54)

Deadline: 2011-05-11; 2011-10-03

Wellcome Trust/ DBT India Alliance

Senior and Intermediate Fellowships for Researchers in India

Deadline: 2011-05-12

Department of Health and Human Services. National Institutes of Health

Chemical Approaches to Target Validation for Drug Resistant Pathogens (R01)

Deadline: 2011-05-13; 2011-06-15

National Science Foundation

Metabolomics for a Low Carbon Society

Deadline: 2011-05-13

Department of Health and Human Services. National Institutes of Health

Centers for AIDS Research and Developmental Centers for AIDS Research (P30)">Centers for AIDS Research and Developmental Centers for AIDS Research (P30)

Deadline: 2011-05-13; 2011-06-14; 2012-05-14; 2012-06-14

Preeclampsia Foundation

Vision Grant Award Program

Deadline: 2011-05-16

Department of Health and Human Services. National Institutes of Health

Economics of Retirement (R03)

Deadline: 2011-05-16; 2011-06-16; 2011-10-16; 2012-02-16

Department of Health and Human Services. National Institutes of Health

Economics of Retirement (R21)

Deadline: 2011-05-16; 2011-06-16; 2011-10-16; 2012-02-16

Department of Health and Human Services. National Institutes of Health

Research Opportunities in Obstetric Fistula (R03)

Deadline: 2011-05-16; 2011-06-16; 2011-10-16; 2012-02-16

Department of Health and Human Services. National Institutes of Health

Research Opportunities in Obstetric Fistula (R21)

Deadline: 2011-05-16; 2011-06-16; 2011-10-16; 2012-02-16

Department of Health and Human Services. National Institutes of Health

Life After Linkage: The Future of Family Studies (R01)

Deadline: 2011-05-16; 2011-06-15

Department of Health and Human Services. National Institutes of Health

NEI Genomic Research Grant on Integrative Data Analysis for Vision Research (R01)

Deadline: 2011-05-18

Department of Health and Human Services. National Institutes of Health

Studies in Neonatal Hypoglycemia (R03)

Deadline: 2011-05-18; 2011-06-16; 2011-09-17; 2011-10-16

Department of Health and Human Services. National Institutes of Health

Studies in Neonatal Hypoglycemia (R21)

Deadline: 2011-05-18; 2011-06-16; 2011-09-17; 2011-10-16

Department of Health and Human Services. National Institutes of Health

Developmental Pharmacology (R03)

Deadline: 2011-05-18; 2011-06-16; 2011-09-17; 2011-10-16

Department of Health and Human Services. National Institutes of Health

Mechanisms of Adverse Drug Reactions in Children (R03)

Deadline: 2011-05-18; 2011-06-16; 2011-09-18; 2011-10-16

Department of Health and Human Services. National Institutes of Health

Developmental Pharmacology (R21)

Deadline: 2011-05-18; 2011-06-16; 2011-09-17; 2011-10-16

German Federal Ministry of Education and Research, Projektträger im DLR

Bernstein Award 2011

Deadline: 2011-05-20

American Society of Human Genetics

Genetics Education Research Program

Deadline: 2011-05-20

Department of Health and Human Services. National Institutes of Health

Optimizing Fidelity of Empirically-Supported Behavioral Treatments for Mental Disorders (R21/R33)

Deadline: 2011-05-20; 2011-06-20

GrantsNet Sponsorship

Sponsorship opportunities are now available on GrantsNet and GrantsNet Express. Please contact Tracy Holmes for more information.

[ top ]

Donisha Adams is the GrantsNet Program Associate.

10.1126/science.caredit.f20110422